Biogen boosts Aduhelm confirmatory trial amid fight for wider Medicare coveragenews2022-01-27T10:13:01+00:00January 27th, 2022|Fierce Pharma|
Lilly, BMS drugs join top TV ad spenders in December as Dupixent stays on topnews2022-01-27T09:43:40+00:00January 27th, 2022|Fierce Pharma|
Fujifilm’s cell therapy ambitions grow with $100M Atara plant buynews2022-01-26T23:42:55+00:00January 26th, 2022|Fierce Pharma|
Michigan attorney general files to investigate Lilly for insulin pricing under the state’s consumer protection lawnews2022-01-26T20:37:33+00:00January 26th, 2022|Fierce Pharma|
Catalent completes $10M expansion at US and UK production sitesnews2022-01-26T18:15:03+00:00January 26th, 2022|Fierce Pharma|
Cancer screening rates still down 2 years into pandemic, as report calls for a continued push for awarenessnews2022-01-26T18:10:50+00:00January 26th, 2022|Fierce Pharma|
New report joins calls from Roche, AstraZeneca to boost cancer screening as rates still down 2 years into pandemicnews2022-01-26T18:10:50+00:00January 26th, 2022|Fierce Pharma|
Court ruling on bluebird bio’s gene therapy marketing campaign ‘sparks’ dismay at Roche’s Sparknews2022-01-26T16:12:23+00:00January 26th, 2022|Fierce Pharma|
BioNTech preps hiring spree at mRNA vaccine plant, boosting workforce by 50%news2022-01-26T16:04:46+00:00January 26th, 2022|Fierce Pharma|
Immunocore wins FDA nod for first uveal melanoma treatment, also first T-cell receptor therapeuticnews2022-01-26T15:21:48+00:00January 26th, 2022|Fierce Pharma|
